[ 7 , 8 , 12 ] Nevertheless, this difference was highly significant, but perhaps quantitatively insufficient to allow to merge clinical outcome differences other than hypoglycaemia events, as reported in other trials [ 7 , 8 , 12 ].
← all excerpts
Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.
1
—
—